ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $235,967 | +8.6% | 73,510 | +7.3% | 0.04% | -2.2% |
| Q3 2023 | $217,205 | -24.7% | 68,519 | +18.0% | 0.05% | -20.7% |
| Q2 2023 | $288,489 | +10.7% | 58,046 | +10.0% | 0.06% | -22.7% |
| Q1 2023 | $260,625 | -0.9% | 52,758 | +26.2% | 0.08% | -70.6% |
| Q4 2022 | $262,928 | -60.3% | 41,801 | -31.8% | 0.26% | -58.1% |
| Q3 2022 | $662,000 | -35.5% | 61,294 | -31.9% | 0.61% | -22.2% |
| Q2 2022 | $1,026,000 | +21.4% | 89,992 | -3.0% | 0.78% | +96.2% |
| Q1 2022 | $845,000 | -52.6% | 92,755 | -22.4% | 0.40% | -38.7% |
| Q4 2021 | $1,784,000 | – | 119,547 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
| Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
| TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
| EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
| CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
| Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
| CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
| Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
| Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
| Navalign, LLC | 75,365 | $238,907 | 0.09% |